Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Calvo Beguería E, Martinez Huguet C, Gonzalez García MP, Omiste SanVicente T. [Sprue-like enteropathy in the elderly treated with olmesartan]. Rev Esp Geriatr Gerontol 2017;52:223-224. [PMID: 28277303 DOI: 10.1016/j.regg.2016.09.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2016] [Revised: 08/24/2016] [Accepted: 09/09/2016] [Indexed: 06/06/2023]

For:	Calvo Beguería E, Martinez Huguet C, Gonzalez García MP, Omiste SanVicente T. [Sprue-like enteropathy in the elderly treated with olmesartan]. Rev Esp Geriatr Gerontol 2017;52:223-224. [PMID: 28277303 DOI: 10.1016/j.regg.2016.09.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2016] [Revised: 08/24/2016] [Accepted: 09/09/2016] [Indexed: 06/06/2023]

Number	Cited by Other Article(s)
1	Rovira-Illamola M, Pagès-Puigdemont N, Sotoca-Momblona JM, Mensa-Vendrell M, Barba-Ávila O, Casasayas-Guilera M. Pharmacy and therapeutics committees strategy to address olmesartan safety issues at a primary care level. Int J Clin Pharm 2020;42:737-743. [DOI: 10.1007/s11096-020-00993-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2019] [Accepted: 02/10/2020] [Indexed: 11/24/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Rovira-Illamola M, Pagès-Puigdemont N, Sotoca-Momblona JM, Mensa-Vendrell M, Barba-Ávila O, Casasayas-Guilera M. Pharmacy and therapeutics committees strategy to address olmesartan safety issues at a primary care level. Int J Clin Pharm 2020;42:737-743. [DOI: 10.1007/s11096-020-00993-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2019] [Accepted: 02/10/2020] [Indexed: 11/24/2022]